OOIR: Observatory of International Research

Papers

(The median citation count of Diabetes & Vascular Disease Research is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
The association between osteoprotegerin and arterial stiffness in a 10-year longitudinal study of patients with type 2 diabetes	191
Longitudinal profiling and tracking stability in the Singapore study of macro-angiopathy and microvascular reactivity in type 2 diabetes cohort	45
Progression of insulin resistance in individuals with type 1 diabetes: A retrospective longitudinal study on individuals from Thailand	31
The role of high mobility group box-1 on the development of diabetes complications: A plausible pharmacological target	28
MicroRNA-451a downregulation in liraglutide-treated individuals with diabetes: A potential cardiovascular protective mechanism	26
Predictive value of lncRNA DBH-AS1 for cardiovascular events in patients with type 2 diabetes mellitus with coronary heart disease	24
Plasma proteomics reveals an improved cardio-metabolic profile in patients with type 2 diabetes post-liraglutide treatment	18
Disruption of COMMD1 accelerates diabetic atherosclerosis by promoting glycolysis	18
RNA-based diagnostic innovations: A new frontier in diabetes diagnosis and management	15
Use of flash glucose monitoring is associated with HbA1c reduction in type 2 diabetes managed with basal insulin in Canada: A real-world prospective observational study	14
Alteration of autophagy-related protein 5 (ATG5) levels and Atg5 gene expression in diabetes mellitus with and without complications	14
“Arterial stiffness is not associated with changes in the circadian pattern of blood pressure in patients with type 1 diabetes mellitus and cardiovascular autonomic dysfunction”	13
Coronary artery calcium score and coronary computed tomography angiography predict one-year mortality in patients with type 2 diabetes and peripheral artery disease undergoing partial foot amputation	12
Health care registers can be instrumental for endpoint capture in clinical diabetes trials: example of microvascular complications in Swedish patients with type 2 diabetes	12
Molecular mechanisms of diabetic heart disease: Insights from transcriptomic technologies	12
Lipoprotein (a) as a predictor of diabetic retinopathy in patients with type 2 diabetes: A systematic review	12
High serum Bhlhe40 levels are associated with subclinical atherosclerosis in patients with type 2 diabetes mellitus: A cross-sectional study	12
Association of hemoglobin glycation index with prognosis of coronary artery disease after percutaneous coronary intervention: A retrospective cohort study	12
Ten-year incidence of post-transplant Diabetes Mellitus in renal transplant patients	11
Cardiometabolic risk factors, peripheral arterial tonometry and metformin in adults with type 1 diabetes participating in the REducing with MetfOrmin Vascular Adverse Lesions trial	11
TyG-BMI and hypertension in Normoglycemia subjects in Japan: A cross-sectional study	11
Trends in cardiovascular burden and mortality among adults with prediabetes in the US, 1999–2018	11
Shared and specific biological signalling pathways for diabetic retinopathy, peripheral neuropathy and nephropathy by high-throughput sequencing analysis	10
Epicardial adipose tissue and right ventricular function in type 2 diabetes mellitus using two-dimensional speckle tracking echocardiography	10
Temporal trends in minor and major lower extremity amputation in people with type 2 diabetes: The Fremantle Diabetes Study	10

Diabetic nephropathy ameliorated in patients with normal home blood pressure compared to those with isolated high home systolic blood pressure: A 5-year prospective cohort study among patients with ty	9
Aspirin use in patients with diagnosed diabetes in the United States and China: Nationally representative analysis	9
Mitochondrial mitophagy protection combining rivaroxaban and aspirin in high glucose-exposed human coronary artery endothelial cell. An in vitro study	9
Function outperforms morphology in the assessment of muscular contribution to insulin sensitivity in premenopausal women	9
Diabetes mellitus does not alter mortality or hospitalisation risk in patients with newly diagnosed heart failure with preserved ejection fraction: Time to rethink pathophysiological models of disease	9
Visceral adipose tissue accumulation and risk of organ complications among individuals with type 2 diabetes mellitus: A two-sample Mendelian randomization study	9
miR-1187 induces podocyte injury and diabetic nephropathy through autophagy	8
Glycemic control and outcome after carotid intervention in patients with T2D: A Swedish nationwide cohort study	8
A cross-sectional study exploring the relationship between oxidative balance score and 10-year atherosclerotic cardiovascular disease risk based on the National Health and Nutrition Examination Survey	8
US eligibility and preventable cardiovascular disease events from semaglutide in type 2 diabetes	8
Letter to editor: Comments on “Early diagnosis value of lncRNA SNHG14 combined with miR-493-5p in gestational diabetes mellitus and its correlation with pregnancy outcome”	8
Early diagnosis value of lncRNA SNHG14 combined with miR-493-5p in gestational diabetes mellitus and its correlation with pregnancy outcome	8
Glucose variability is associated with an adverse vascular profile but only in the presence of insulin resistance in individuals with type 1 diabetes: An observational study	7
The association between sodium-glucose cotransporter 2 inhibitors and incident dementia: A nationwide population-based longitudinal cohort study	7
Predictors of coronary artery calcium burden in asymptomatic patients with newly diagnosed type 2 diabetes mellitus	6
Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis	6
Responses of retinal and brain microvasculature to streptozotocin induced diabetes revealed by global expression profiling	6
Predictive power of isolated high home systolic blood pressure for cardiovascular outcomes in individuals with type 2 diabetes mellitus: KAMOGAWA-HBP study	6
Bioinformatics analyses of potential microRNAs and their target genes in myocardial infarction patients with diabetes	6
Ultra-high frequency ultrasound delineated changes in carotid and muscular artery intima-media and adventitia thickness in obese early middle-aged women	6
Type 1 diabetes mellitus disease burden in high health expenditure countries between 1990 and 2019	5
Impact of diabetes on long-term all-cause re-hospitalization after revascularization with percutaneous coronary intervention	5
Restoration of coronary microvascular function by OGA overexpression in a high-fat diet with low-dose streptozotocin-induced type 2 diabetic mice	5
Use of continuous glucose monitoring trend arrows in the younger population with type 1 diabetes	5
Glycaemic variability and risk of adverse cardiovascular events in acute coronary syndrome	5
Patient-important outcomes in type 2 diabetes: The paradigm of the sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists	5
Combined effect of body mass index and atherogenic index of plasma on risk of stroke among individuals with abnormal glucose metabolism: Evidence from the China health and retirement longitudinal stud	4
Impact of diabetes on outcomes of cardiogenic shock: A systematic review and meta-analysis	4
The impact of semaglutide on wound healing in diabetes related foot ulcer patients: A TriNetX database study	4
Prevalence and risk factors of retinal vein occlusion in individuals with diabetes: The kailuan eye study	4
Associations of prognostic nutritional index with risk of all-cause and cardiovascular disease mortalities in persons with gestational diabetes mellitus: A NHANES-based analysis	4
Cardiovascular risk factors, exercise capacity and health literacy in patients with chronic ischaemic heart disease and type 2 diabetes mellitus in Germany: Baseline characteristics of the Lifestyle I	4
Mid-term safety and efficacy of magnesium bioresorbable vascular scaffolds – magmaris in diabetic population. 2-Years outcome in acute coronary syndrome cohort	4
Impact of COVID-19 therapy on hyperglycemia	4
Five-year outcomes of patients with diabetes mellitus treated with a sirolimus-eluting or a biolimus-eluting stents with biodegradable polymer. From the SORT OUT VII trial	4